Viva BioInnovator

VC · Shanghai (China)

VC

Pre-Seed

Seed

Sign up free to access full profile and submit your pitch.

About

Viva BioInnovator is a venture capital arm of Viva Biotech Holdings, specializing in incubation, seed, start-up, and early stage investments. The firm typically invests in biotech companies across all indications and drug types, especially companies with innovative solutions for unmet medical needs cross multiple therapeutic areas. It seeks to invest in companies based in the United States and also companies globally. The firm prefers investing in companies which fully utilize VBI drug discovery services particularly in innovative spaces such as gene and cell therapy. It seeks to invest between USD 0.5 million to USD 5 million for each investment. The firm typically invests in firms with market potential 5 to 10 years in the future. Viva BioInnovator was founded in 2014 and is based in Shanghai, China.

Investment Criteria

Other investors that have backed the same portfolio companies as Viva BioInnovator. Expand any entry to see the shared portfolio companies.

• Lumira Ventures

  4 shared

  Shared portfolio companies

  • AmacaThera Inc.
  • Bright Angel Therapeutics Inc.
  • Deka BioSciences, Inc.
  • Iterion Therapeutics, Inc.
• Mission BioCapital

  3 shared

  Shared portfolio companies

  • Mediar Therapeutics, Inc.
  • QurAlis Corporation
  • Telo Therapeutics, Inc.
• Shenzhen Capital Group (SCGC)

  3 shared

  Shared portfolio companies

  • Genhouse Medicine (Suzhou) Co., Ltd.
  • Qiyu Biotechnology (Shanghai) Co., Ltd.
  • Qure Biotechnology Co., Ltd.
• Sofinnova Partners

  3 shared

  Shared portfolio companies

  • Domain Therapeutics SA
  • HAYA Therapeutics SA
  • Mediar Therapeutics, Inc.
• ATEM Capital

  2 shared

  Shared portfolio companies

  • Deka BioSciences, Inc.
  • Triumvira Immunologics Inc.
• CTI Life Sciences

  2 shared

  Shared portfolio companies

  • Domain Therapeutics SA
  • Phenomic AI Inc.
• Insight Partners

  2 shared

  Shared portfolio companies

  • ArrePath, Inc.
  • Basking Biosciences, Inc.
• Leaps by Bayer

  2 shared

  Shared portfolio companies

  • Deka BioSciences, Inc.
  • Triumvira Immunologics Inc.
• Mission Bay Capital

  2 shared

  Shared portfolio companies

  • QurAlis Corporation
  • Telo Therapeutics, Inc.
• Panacea Venture Management Co., Ltd.

  2 shared

  Shared portfolio companies

  • Domain Therapeutics SA
  • GT Apeiron Therapeutics